Abbott Laboratories
NYSE: ABT
$117.97
+$0.21 (+0.2%)
Real Time Data Delayed 15 Min.
ABT Stock Chart and Intraday Price
ABT Stock Data
| Asset Type | Stock |
| Exchange | NYSE |
| Currency | USD |
| Country | USA |
| Sector | LIFE SCIENCES |
| Industry | PHARMACEUTICAL PREPARATIONS |
| Address | 100 ABBOTT PARK ROAD, ABBOTT PARK, IL, US |
| Fiscal Year End | December |
| Latest Quarter | 12/31/2023 |
| Market Cap | 205,827.06M USD |
| Shares Outstanding | 1,735,180,000 |
ABT Articles
AbbVie has rewarded shareholders again with a quarterly dividend. As a Dividend King, it is the epitome of a steady and reliable stock.
Published:
A recession is looming. Despite the S&P 500 nearing its all-time high, the yield curve inverted and the Sahm Rule was activated. The Federal Reserve is also poised to initiate the first interest...
Published:
Investors have been on a roller coaster ride for the past four years and the stock market may be heading into another big loop higher. Federal Reserve chairman Jay Powell gave his strongest...
Published:
24/7 Wall St. Insights Stocks that consistently raise their dividends offer investors huge total return potential. Dividend stocks will become more popular as interest rates decline. Grab this free...
Published:
24/7 Insights AI stocks are facing headwinds and sky high valuations are cooling down J.P. Morgan’s top picks are in May are stable, established brands 2 legendary, high-yield dividend stocks Wall...
Published:
Here is an assessment of how safe the dividend at AbbVie appears to be based on a variety of metrics, including its status as a Dividend Aristocrat.
Published:
Here is an assessment of how safe the dividend at Abbott Laboratories appears to be based on a variety of metrics, including its status as a Dividend Aristocrat.
Published:
These eight top Dividend Aristocrats pay among the biggest dividends in the sectors that typically do well during a recession. With even moderate appreciation in their share prices, investors should...
Published:
Wednesday's top analyst upgrades and downgrades included Abbott Laboratories, Boston Scientific, ChargePoint, Coinbase Global, Dollar General, Equitrans Midstream, Ford, Hasbro, Johnson & Johnson,...
Published:
Before U.S. markets open on Wednesday, these four companies are set to report quarterly earnings.
Published:
Thursday's top analyst upgrades and downgrades included Abbott Laboratories, Carnival, Deere, Delta Air Lines, DexCom, Enovix, First Republic Bank, GitLab, Hartford Financial Services, Interpublic...
Published:
U.S. equities are trading somewhat higher in Tuesday's premarket session as investors wait to hear what Federal Reserve chief Jerome Powell has to say to Congress.
Published:
With the potential for big downside still looming, and interest rates definitely headed higher, stock investors may want to consider these seven Dividend Aristocrats that posted solid third-quarter...
Published:
Thursday's top analyst upgrades and downgrades included Abbott Laboratories, Biohaven, Edwards Lifesciences, Enphase Energy, Halliburton, Invesco, Liberty Energy, Mattel, Netflix, Permian Resources,...
Published:
Here is a look at what to expect from these four companies when they report quarterly results before markets open on Wednesday.
Published: